Viatris enters agreement to sell OTC business to Cooper Consumer Health for up to €1.95B

On October 1,2023, Viatris Inc., a Delaware corporation (“ Viatris ” or the “ Company ”) entered into an agreement with Cooper Consumer Health SAS, a French corporation (“ Buyer Parent ”) pursuant to which Buyer Parent made a binding offer (“ the Offer ”), by irrevocably granting Viatris an option (the “ Option ”), to require the Buyer Parent and certain of its affiliates (collectively, the “ Buyer Parties ”) to purchase and assume, as applicable, substantially all of Viatris’ over-the-counter products business (the “ Business ”) and related assets and liabilities, on the terms and subject to the conditions of a negotiated form of Transaction Agreement described below (such form, the “ Transaction Agreement ” and such potential transaction, the “ Transaction ”).